$0.0495
-0.0005[-1.00%]
At close: Apr 19
Evelo Biosciences
(OTCPK:EVLO)Latest News for Evelo Biosciences Stock (OTC:EVLO)
Evelo Biosciences Stock (OTC: EVLO)
Categories: All
Wednesday, December 06, 2023
Friday, November 24, 2023
Friday, November 17, 2023
Wednesday, November 15, 2023
Monday, November 06, 2023
Friday, November 03, 2023
Friday, October 20, 2023
Wednesday, October 18, 2023
- 12 Health Care Stocks Moving In Wednesday's After-Market SessionBenzinga Insights - Oct 18, 2023, 5:31PM
- Evelo Biosciences shares are trading lower after TD Cowen downgraded the stock from Outperform to Market Perform.Benzinga Newsdesk - Oct 18, 2023, 1:14PM
- Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2023Benzinga Insights - Oct 18, 2023, 11:00AM
- TD Cowen Downgrades Evelo Biosciences to Market PerformBenzinga Newsdesk - Oct 18, 2023, 4:44AM
Tuesday, October 17, 2023
- Crude Oil Moves Lower; Bank of America Profit Beats ExpectationsLisa Levin - Oct 17, 2023, 2:31PM
- Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Oct 17, 2023, 1:42PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Oct 17, 2023, 1:31PM
- Dow Surges 100 Points; Goldman Sachs Posts Upbeat EarningsLisa Levin - Oct 17, 2023, 11:56AM
- Evelo Biosciences shares are trading lower after the company reported the primary endpoint in its Phase 2 clinical study with EDP2939 in moderate psoriasis was not achieved. The company also initiated a process to explore strategic alternatives.Benzinga Newsdesk - Oct 17, 2023, 10:23AM
- Nasdaq Down Over 1%; US Retail Sales Top ExpectationsLisa Levin - Oct 17, 2023, 10:01AM
- Why Is Psoriasis Company Evelo Biosciences Stock Plunging Today?Vandana Singh - Oct 17, 2023, 9:49AM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Oct 17, 2023, 9:06AM
- Evelo Biosciences Shares Resume TradeBenzinga Newsdesk - Oct 17, 2023, 7:32AM
- Assembly Biosciences, Inc. Shares To Resume Trade At 7:30 a.m. ET,; Evelo Biosciences, Inc. CS Shares To Resume Trade At 7:30 a.m. ETCharles Gross - Oct 17, 2023, 7:09AM
- Evelo Biosciences Initiates Process To Explore Strategic Alternatives; Seeks Partnering Opportunities For EDP1815 And Its SINTAX PlatformBenzinga Newsdesk - Oct 17, 2023, 7:03AM
- Evelo Biosciences Reports Top-Line Results From Its Phase 2 Clinical Study With EDP2939 In Moderate Psoriasis; Primary Endpoint Was Not AchievedBenzinga Newsdesk - Oct 17, 2023, 7:01AM
- Evelo Biosciences, Assembly Biosciences Shares Halted; Pending NewsCharles Gross - Oct 17, 2023, 6:57AM
Wednesday, October 11, 2023
Thursday, September 07, 2023
Friday, August 18, 2023
Wednesday, July 26, 2023
Monday, July 24, 2023
Friday, July 21, 2023
- Evelo Biosciences 13G Filing Shows Horizon Technology Finance Corporation Increases Stake In Co To 11.5% As Of July 11Happy Mohamed - Jul 21, 2023, 3:50PM
- Why Metropolitan Bank Holding Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Jul 21, 2023, 1:00PM
- Scholastic, Matson, Digital World Acquisition And Other Big Stocks Moving Higher On FridayLisa Levin - Jul 21, 2023, 10:23AM
- Dow Rises 50 Points; American Express Earnings Top ViewsLisa Levin - Jul 21, 2023, 9:53AM
- Why Are Evelo Biosciences Stock Is Trading Higher Today?Vandana Singh - Jul 21, 2023, 9:48AM
- Evelo Biosciences Shares Resume TradeHappy Mohamed - Jul 21, 2023, 9:47AM
- Evelo Biosciences Shares Halted On Circuit Breaker To The Upside, Stock Now Up 34.4%Happy Mohamed - Jul 21, 2023, 9:41AM
Thursday, July 20, 2023
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Jul 20, 2023, 5:32PM
- Evelo Biosciences Terminated Their Sublease Agreement With Bio-Rad Laboratories, Agreeing To Make A Termination Payment Of $523,556 And Allowing Bio-Rad To Draw On A Letter Of Credit For $850,000 With The Potential For An Additional Payment Of Up To $2.5MBenzinga Newsdesk - Jul 20, 2023, 4:49PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Jul 20, 2023, 1:30PM